ihl-675a
Generic: cannabidiol and hydroxychloroquine sulfate
ihl-675a: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Incannex Healthcare Inc. (IXHL) | Phase 2 |
Clinical Trials (1)
A Phase II, Blinded, Randomised, Placebo Controlled Clinical Trial to Determine the Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
Frequently asked questions
Who is developing ihl-675a?
ihl-675a is being developed by Incannex Healthcare Inc..
How many clinical trials involve ihl-675a?
BioSniper tracks 1 clinical trial involving ihl-675a.
Get deeper analysis on ihl-675a
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis